Invivogen
Menu

NLRC4 KO RAW-ASC Cells

RAW-ASC KO-NLRC4 Cells Unit size Cat. code Docs Qty Price
NLRC4 Knockout & ASC expressing RAW 264.7 cells (murine macrophages)
3-7 x 10e6 cells
raw-konlrc4
+-
$1,373.00

You may also need : LFn-Rod | View more associated products

NLRC4 knockout in RAW 264.7 cells

 Inflammasome signaling in RAW-ASC KO-NLRC4 cells
Inflammasome signaling in RAW-ASC KO-NLRC4 cells

NLRC4 (Nucleotide-binding domain (NBD) and leucin-rich repeat (LRR) receptor, CARD domain-containing protein 4, or IPAF) is a cytoplasmic protein which upon activation, triggers the assembly of an NLRC4 inflammasome [1-3].

 More details

 

InvivoGen has generated RAW-ASC KO-NLRC4 cells from the RAW-ASC cell line, which derives from the naturally ASC-deficient RAW 264.7 macrophage cell line [4]. RAW-ASC KO-NLRC4 cells stably express the transfected murine ASC gene and feature a stable knockout of the NLRC4 gene. 

• RAW-ASC KO-NLRC4 cells – Knockout (KO) of the NLRC4 gene and expression of the murine ASC gene

These cells exhibit impaired IL-1β secretion and pyroptosis upon incubation with known inducers of the NLRC4 inflammasome. Importantly, IL-1β secretion and pyroptosis remain unaffected upon incubation with other inflammasome inducers such as Nigericin (NLRP3 inducer).

 

FEATURES OF RAW-ASC KO-NLRC4 CELLS:

  • Absence of functional NLRC4 protein expression
  • Verified biallelic knockout of the NLRC4 gene (DNA sequencing, PCR, and Western blot)
  • Altered IL-1β secretion and pyroptosis early upon NLRC4 inflammasome activation

 

Download our Practical guide on Inflammasomes

 

References:

1. Zhang L. et al., 2015. Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization. Science. 350:404-409.
2. Zhao Y. et al., 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature. 477: 596-600.
3. Bauer R. & Rauch I., 2011. The NAIP/NLRC4 inflammasome in infection and pathology. Mol. Aspects Med. 2020 Jun 1:100863.
4. Pelerin P. et al., 2008. P2X7 receptor differentially couples to distinct release pathways for IL-1β in mouse macrophage. J. Immunol. 180:7147.

Figures

Validation of NLRC4 Knockout (KO)
Validation of NLRC4 Knockout (KO)

Validation of NLRC4 KO in RAW-ASC KO-NLRC4 cells by PCR and Western blot (WESTM).
(A) The targeted NLRC4 region in RAW-ASC (WT) and RAW-ASC KO-NLRC4 (KO) cells was amplified by PCR. RAW-ASC KO-NLRC4 cells feature a biallelic deletion (arrow).
(B) Lysates from RAW-ASC (ASC) and RAW-ASC KO-NLRC4 (KO) cells were analyzed by Western blot (WesTM) using an NLRC4 antibody (Abcam, ref 201792), followed by a HRP‑conjugated anti-rabbit secondary antibody.
The arrow indicates the band for the NLRC4 protein (expected size ~115 kDa).

Functional validation of RAW-ASC KO-NLRC4 cells
Functional validation of RAW-ASC KO-NLRC4 cells

Secretion of mature IL-1β by RAW-ASC KO-NLRC4 cells and their parental RAW-ASC cells upon inflammasome activation.
~2x105 RAW-ASC (WT) and RAW-ASC KO‑NLRC4 (KO) cells were incubated for 3h at 37°C with Pam3CSK4 (100 ng/ml) (priming) and then incubated (activation) with inflammasome inducers: Nigericin (5 μM), transfected Poly (dA:dT) (1 μg/ml), Rod-Tox (2 μg/ml). After 24h, the secretion of mature IL-1β was assessed in the culture supernatant using an ELISA assay.
Note: Rod-Tox is a combination of LFn-Rod (2 μg/ml) with the anthrax protective antigen (PA) (1 μg/ml). PA allows LFn-Rod translocation into the cytosol.

Back to the top

Specifications

Antibiotic resistance: Blasticidin

Growth medium: DMEM, 4.5 g/l glucose, 4 mM L-glutamine, 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin, 100 µg/ml streptomycin, 100 µg/ml Normocin™

Test medium: DMEM without phenol red, 4.5 g/l glucose, 4 mM L-glutamine, 10% heat-inactivated FBS, 100 U/ml penicillin, 100 µg/ml streptomycin.
Note: Phenol red causes high background signal in the LDH (lactate dehydrogenase) assay used to monitor inflammasome-induced cell death.

Quality Control:

  • Biallelic murine NLRC4 knockout has been verified by Western blot (Wes™) and functional assays.
  • The stability for 20 passages, following thawing, has been verified. 
  • These cells are guaranteed mycoplasma-free. 

This product is covered by a Limited Use License (See Terms and Conditions).

Back to the top

Contents

  • 3-7 x 106 RAW-ASC KO-NLRC4 cells in a cryovial or shipping flask
  • 1 ml of Normocin™ (50 mg/ml). Normocin™ is a formulation of three antibiotics active against mycoplasma, bacteria, and fungi.
  • 1 ml of Blasticidin (10 mg/ml)

 Shipped on dry ice (Europe, USA & Canada)

Back to the top

Details

Inflammasomes are cytoplasmic multi-protein complexes, characterized by a primary sensor, that assemble in response to infections and cellular damage. NLRC4 is an indirect sensor that must associate with NAIP (NLR family apoptosis inhibitory protein) to induce the assembly of an NLRC4 inflammasome. A single NAIP operates upstream of NLRC4 in humans and recognizes intracellular Flagellin, Needle, or Rod from several Gram-negative bacterial strains [1]. These ligands are sensed by NAIP upon bacterial invasion, or cytosolic translocation through the bacterial type III or IV secretion systems (T3SS or T4SS). Once recruited by NAIP, NLRC4 triggers a homo-polymerization through NBD-NBD interactions, allowing a CARD clustering [1]. The NLCR4 polymer further associates to pro-caspase-1, either through direct CARD-CARD interaction or through the binding of the ASC (apoptosis-associated speck-like protein) adaptor [1]. Activation of caspase-1 induces the maturation of pro-IL-1β/pro-IL-18, cleavage of the pore-forming gasdermin D (GSDMD), secretion of IL-1β/-18, and pyroptosis [1-3]. The NLRC4 inflammasome appears to protect mucosal barriers such as the lung, stomach, and intestine from invading bacteria [2]. Gain-of-function mutations have been described in human NLRC4 and are associated with auto-inflammatory conditions [3]. 

 

1. Zhang L. et al., 2015. Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization. Science. 350:404-409.
2. Zhao Y. et al., 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature. 477: 596-600.
3. Bauer R. & Rauch I., 2011. The NAIP/NLRC4 inflammasome in infection and pathology. Mol. Aspects Med. 2020 Jun 1:100863.

Back to the top

FAQ

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top
Customer Service
& Technical Support
Shopping cart is empty